Current role
Biotechnology · Healthcare
Board Member
2025-08-11–present
Bihua Chen
Board Member
BridgeBio Oncology Therapeutics, Inc. (BBOT)Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Oncology Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBOT alertsAbout Bihua Chen
Bihua Chen is recorded as Board Member at BridgeBio Oncology Therapeutics, Inc. (BBOT) since August 11, 2025. BridgeBio Oncology Therapeutics, Inc. reported in an 8-K filed August 13, 2025 that Bihua Chen was appointed Class II director, effective August 11, 2025. BridgeBio Oncology Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Oncology Therapeutics, Inc. includes Eli Wallace (CEO and Board Member), Pedro Beltran, Ph.D. (CEO and Board Member), Pedro J. Beltran, Ph.D. (CEO and Board Member) and 7 others.
“Effective immediately following the Merger Effective Time, Eli Wallace, Neil Kumar, Frank McCormick, Praveen Tipirneni, Michelle Doig, Bihua Chen, Raymond Kelleher, and Jake Bauer were appointed to constitute members of the PubCo Board”
Affiliation history
-
Current
2025-08-11–present
Company network
Leadership on record at BridgeBio Oncology Therapeutics, Inc.
- Eli Wallace CEO, Board Member
- Pedro Beltran, Ph.D. CEO, Board Member
- Pedro J. Beltran, Ph.D. CEO, Board Member
- Neil Kumar, Ph.D. Chairman
- Idan Elmelech CFO, COO
- Uneek Mehra CFO
- Marc Cobo Chief Accounting Officer
- Albert A. Holman, III Board Member
- Frank McCormick Board Member
- Frank P. McCormick Board Member